Receptor for advanced glycation end-products signaling interferes with the vascular smooth muscle cell contractile phenotype and function

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Simard, Elie ^a   Söllradl, Thomas ^a   Maltais, Jean Sébastien ^a   Boucher, Julie ^a   D'Orléans Juste, Pédro ^a,b   Grandbois, Michel ^a,b  

^a UNIVERSITY OF SHERBROOKE   (Canada)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; CALCIUM; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MYOCARDIN; MYOSIN; TRANSGELIN; VASOPRESSIN; GLYCOSYLATED SERUM ALBUMIN; SERUM ALBUMIN;

ANIMAL CELL; ARTICLE; CALCIUM SIGNALING; CONTROLLED STUDY; DIABETES MELLITUS; MUSCLE FIBER CONTRACTION; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE CELL; ANIMAL; BIOMECHANICS; CELL LINE; CYTOLOGY; DIABETES COMPLICATIONS; HUMAN; METABOLISM; MUSCLE CONTRACTION; PHYSIOLOGY; VASCULAR DISEASES; VASCULAR SMOOTH MUSCLE;

ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; ANIMALS; BIOMECHANICAL PHENOMENA; CALCIUM; CELL LINE; DIABETES COMPLICATIONS; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NF-KAPPA B; RATS; SERUM ALBUMIN; SIGNAL TRANSDUCTION; VASCULAR DISEASES;

EID: 84942256835     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0128881     Document Type: Article

References (73)

1. Chilelli NC, Burlina S, Lapolla A. (2013) AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: A "glycoxidation-centric" point of view. Nutr Metab Cardiovasc Dis 23: 913-919. doi: 10.1016/j.numecd.2013.04.004 PMID: 23786818
2. Singh R, Barden A, Mori T, Beilin L. (2001) Advanced glycation end-products: A review. Diabetologia 44: 129-146. PMID: 11270668
3. Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan D, et al. (2004) Tests of glycemia in diabetes. Diabetes Care 27: 1761-1773. PMID: 15220264
4. Hubmayr RD, Shore SA, Fredberg JJ, Planus E, Panettieri RA Jr, et al. (1996) Pharmacological activation changes stiffness of cultured human airway smooth muscle cells. Am J Physiol 271: C1660-8. PMID: 8944650
5. Ikebe R, Reardon S, Mitsui T, Ikebe M. (1999) Role of the N-terminal region of the regulatory light chain in the dephosphorylation of myosin by myosin light chain phosphatase. J Biol Chem 274: 30122-30126. PMID: 10514500
6. Bailey AJ, Sims TJ, Avery NC, Halligan EP. (1995) Non-enzymic glycation of fibrous collagen: Reaction products of glucose and ribose. Biochem J 305 (Pt 2): 385-390. PMID: 7832750
7. Hall A. (1998) Rho GTPases and the actin cytoskeleton. Science 279: 509-514. PMID: 9438836
8. Taguchi A, Blood DC, del Toro G, Canet A, Lee DC, et al. (2000) Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 405: 354-360. PMID: 10830965
9. Goldin A, Beckman JA, Schmidt AM, Creager MA. (2006) Advanced glycation end products: Sparking the development of diabetic vascular injury. Circulation 114: 597-605. PMID: 16894049
10. Hayden MS, Ghosh S. (2012) NF-kappaB, the first quarter-century: Remarkable progress and outstanding questions. Genes Dev 26: 203-234. doi: 10.1101/gad.183434.111 PMID: 22302935
11. Yan SD, Schmidt AM, Anderson GM, Zhang J, Brett J, et al. (1994) Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 269: 9889-9897. PMID: 8144582
12. Chuong C, Katz J, Pauley KM, Bulosan M, Cha S. (2009) RAGE expression and NF-kappaB activation attenuated by extracellular domain of RAGE in human salivary gland cell line. J Cell Physiol 221: 430-434. doi: 10.1002/jcp.21873 PMID: 19591173
13. Tang DD, Anfinogenova Y. (2008) Physiologic properties and regulation of the actin cytoskeleton in vascular smooth muscle. J Cardiovasc Pharmacol Ther 13: 130-140. doi: 10.1177/1074248407313737 PMID: 18212360
14. de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T. (2000) International union of pharmacology. XXIII. the angiotensin II receptors. Pharmacol Rev 52: 415-472. PMID: 10977869
15. Miyazaki H, Hayashi K, Hasegawa Y. (2003) Tensile properties of fibroblasts and vascular smooth muscle cells. Biorheology 40: 207-212. PMID: 12454406
16. Mack CP. (2011) Signaling mechanisms that regulate smooth muscle cell differentiation. Arterioscler Thromb Vasc Biol 31: 1495-1505. doi: 10.1161/ATVBAHA.110.221135 PMID: 21677292
17. Xie C, Ritchie RP, Huang H, Zhang J, Chen YE. (2011) Smooth muscle cell differentiation in vitro: Models and underlying molecular mechanisms. Arterioscler Thromb Vasc Biol 31: 1485-1494. doi: 10.1161/ATVBAHA.110.221101 PMID: 21677291
18. Kislinger T, Fu C, Huber B, Qu W, Taguchi A, et al. (1999) N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J Biol Chem 274: 31740-31749. PMID: 10531386
19. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, et al. (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150: 76-85. PMID: 3843705
20. Cayot P, Tainturier G. (1997) The quantification of protein amino groups by the trinitrobenzenesulfonic acid method: A reexamination. Anal Biochem 249: 184-200. PMID: 9212870
21. Temple A, Yen TY, Gronert S. (2006) Identification of specific protein carbonylation sites in model oxidations of human serum albumin. J Am Soc Mass Spectrom 17: 1172-1180. PMID: 16750385
22. Schneider CA, Rasband WS, Eliceiri KW. (2012) NIH image to ImageJ: 25 years of image analysis. Nat Methods 9: 671-675. PMID: 22930834
23. Brosseau J, Lucier J, Lapointe E, Durand M, Gendron D, et al. (2010) High-throughput quantification of splicing isoforms. RNA 16: 442-449. doi: 10.1261/rna.1877010 PMID: 20038630
24. Hellemans J, Mortier G, De Paepe Anne, Speleman F, Vandesompele J. (2007) qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 8: R19. PMID: 17291332
25. Cuerrier CM, Benoit M, Guillemette G, Gobeil F, Grandbois M. (2009) Real-time monitoring of angiotensin II-induced contractile response and cytoskeleton remodeling in individual cells by atomic force microscopy. Pflugers Arch 457: 1361-1372. doi: 10.1007/s00424-008-0596-0 PMID: 18953565
26. Butt H-, Jashke M. (1995) Thermal noise in atomic force spectroscopy. Nanotechnology 6: 1-7.
27. Rotsch C, Radmacher M. (2000) Drug-induced changes of cytoskeletal structure and mechanics in fibroblasts: An atomic force microscopy study. Biophys J 78: 520-535. PMID: 10620315
28. Boucher J, Simard E, Froehlich U, Grandbois M. (2014) Amplification of AngII-dependent cell contraction by glyoxal: Implication of cell mechanical properties and actomyosin activity. Integr Biol (Camb).
29. Tsien RY, Rink TJ, Poenie M. (1985) Measurement of cytosolic free Ca2+ in individual small cells using fluorescence microscopy with dual excitation wavelengths. Cell Calcium 6: 145-157. PMID: 3874696
30. Nguyen N, Biet M, Simard E, Beliveau E, Francoeur N, et al. (2013) STIM1 participates in the contractile rhythmicity of HL-1 cells by moderating T-type ca(2+) channel activity. Biochim Biophys Acta 1833: 1294-1303. doi: 10.1016/j.bbamcr.2013.02.027 PMID: 23458835
31. Bovenzi V, Savard M, Morin J, Cuerrier CM, Grandbois M, et al. (2010) Bradykinin protects against brain microvascular endothelial cell death induced by pathophysiological stimuli. J Cell Physiol 222: 168-176. doi: 10.1002/jcp.21933 PMID: 19780024
32. Cuerrier CM, Chabot V, Vigneux S, Aimez V, Escher E, et al. (2008) Surface plasmon resonance monitoring of cell monolayer integrity: Implication of signaling pathways involved in actin-driven morphological remodeling. Cell Mol Bioeng 1: 229-239. PMID: 21052479
33. Holmes CL, Landry DW, Granton JT. (2003) Science review: Vasopressin and the cardiovascular system part 1 - receptor physiology. Crit Care 7: 427-434. PMID: 14624682
34. Parker R, Sheth U. (2007) P bodies and the control of mRNA translation and degradation. Mol Cell 25: 635-646. PMID: 17349952
35. Fukata Y, Amano M, Kaibuchi K. (2001) Rho-rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol Sci 22: 32-39. PMID: 11165670
36. Rasmussen H, Takuwa Y, Park S. (1987) Protein kinase C in the regulation of smooth muscle contraction. FASEB J 1: 177-185. PMID: 3040504
37. Olson ES, Dong W. (2006) Nonlinearity in intracochlear pressure. ORL J Otorhinolaryngol Relat Spec 68: 359-364. PMID: 17065830
38. Owens GK, Kumar MS, Wamhoff BR. (2004) Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84: 767-801. PMID: 15269336
39. Suga T, Iso T, Shimizu T, Tanaka T, Yamagishi S, et al. (2011) Activation of receptor for advanced glycation end products induces osteogenic differentiation of vascular smooth muscle cells. J Atheroscler Thromb 18: 670-683. PMID: 21512281
40. Tanikawa T, Okada Y, Tanikawa R, Tanaka Y. (2009) Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK. J Vasc Res 46: 572-580. doi: 10.1159/000226225 PMID: 19571577
41. Valencia JV, Weldon SC, Quinn D, Kiers GH, DeGroot J, et al. (2004) Advanced glycation end product ligands for the receptor for advanced glycation end products: Biochemical characterization and formation kinetics. Anal Biochem 324: 68-78. PMID: 14654047
42. Ikeda K, Higashi T, Sano H, Jinnouchi Y, Yoshida M, et al. (1996) N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the maillard reaction. Biochemistry 35: 8075-8083. PMID: 8672512
43. Reddy S, Bichler J, Wells-Knecht KJ, Thorpe SR, Baynes JW. (1995) N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. Biochemistry 34: 10872-10878. PMID: 7662668
44. Gloire G, Legrand-Poels S, Piette J. (2006) NF-kappaB activation by reactive oxygen species: Fifteen years later. Biochem Pharmacol 72: 1493-1505. PMID: 16723122
45. Liu L, Abramowitz J, Askari A, Allen JC. (2004) Role of caveolae in ouabain-induced proliferation of cultured vascular smooth muscle cells of the synthetic phenotype. Am J Physiol Heart Circ Physiol 287: H2173-82. PMID: 15256370
46. Zhang X, Meng H, Wang MM. (2013) Collagen represses canonical notch signaling and binds to notch ectodomain. Int J Biochem Cell Biol 45: 1274-1280. doi: 10.1016/j.biocel.2013.03.020 PMID: 23579095
47. Schad JF, Meltzer KR, Hicks MR, Beutler DS, Cao TV, et al. (2011) Cyclic strain upregulates VEGF and attenuates proliferation of vascular smooth muscle cells. Vasc Cell 3: 21-824X-3-21.
48. Kimes BW, Brandt BL. (1976) Characterization of two putative smooth muscle cell lines from rat thoracic aorta. Exp Cell Res 98: 349-366. PMID: 943301
49. Wang Z, Wang DZ, Pipes GC, Olson EN. (2003) Myocardin is a master regulator of smooth muscle gene expression. Proc Natl Acad Sci U S A 100: 7129-7134. PMID: 12756293
50. Rensen SS, Doevendans PA, van Eys GJ. (2007) Regulation and characteristics of vascular smooth muscle cell phenotypic diversity. Neth Heart J 15: 100-108. PMID: 17612668
51. Xi XP, Graf K, Goetze S, Fleck E, Hsueh WA, et al. (1999) Central role of the MAPK pathway in ang II-mediated DNA synthesis and migration in rat vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 19: 73-82. PMID: 9888869
52. Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, et al. (2001) Mitogen-activated protein (MAP) kinase pathways: Regulation and physiological functions. Endocr Rev 22: 153-183. PMID: 11294822
53. Hemmings BA, Restuccia DF. (2012) PI3K-PKB/akt pathway. Cold Spring Harb Perspect Biol 4: a011189. doi: 10.1101/cshperspect.a011189 PMID: 22952397
54. Xie P, Fan Y, Zhang H, Zhang Y, She M, et al. (2009) CHIP represses myocardin-induced smooth muscle cell differentiation via ubiquitin-mediated proteasomal degradation. Mol Cell Biol 29: 2398-2408. doi: 10.1128/MCB.01737-08 PMID: 19237536
55. Friedl P, Wolf K. (2003) Tumour-cell invasion and migration: Diversity and escape mechanisms. Nat Rev Cancer 3: 362-374. PMID: 12724734
56. Holle AW, Engler AJ. (2010) Cell rheology: Stressed-out stem cells. Nat Mater 9: 4-6. doi: 10.1038/nmat2589 PMID: 20019660
57. Swaminathan V, Mythreye K, O'Brien ET, Berchuck A, Blobe GC, et al. (2011) Mechanical stiffness grades metastatic potential in patient tumor cells and in cancer cell lines. Cancer Res 71: 5075-5080. doi: 10.1158/0008-5472.CAN-11-0247 PMID: 21642375
58. Berdyyeva TK, Woodworth CD, Sokolov I. (2005) Human epithelial cells increase their rigidity with ageing in vitro: Direct measurements. Phys Med Biol 50: 81-92. PMID: 15715424
59. Ulrich P, Zhang X. (1997) Pharmacological reversal of advanced glycation end-product-mediated protein crosslinking. Diabetologia 40 Suppl 2: S157-9. PMID: 9248729
60. Bucala R, Cerami A. (1992) Advanced glycosylation: Chemistry, biology, and implications for diabetes and aging. Adv Pharmacol 23: 1-34. PMID: 1540533
61. Halka AT, Turner NJ, Carter A, Ghosh J, Murphy MO, et al. (2008) The effects of stretch on vascular smooth muscle cell phenotype in vitro. Cardiovasc Pathol 17: 98-102. doi: 10.1016/j.carpath.2007.03.001 PMID: 18329554
62. Briones AM, Arribas SM, Salaices M. (2010) Role of extracellular matrix in vascular remodeling of hypertension. Curr Opin Nephrol Hypertens 19: 187-194. doi: 10.1097/MNH.0b013e328335eec9 PMID: 20040870
63. Ren J, Albinsson S, Hellstrand P. (2010) Distinct effects of voltage- and store-dependent calcium influx on stretch-induced differentiation and growth in vascular smooth muscle. J Biol Chem 285: 31829-31839. doi: 10.1074/jbc.M109.097576 PMID: 20675376
64. Thatcher SE. (2007) MLCK/actin interaction in the contracting A7r5 cell and vascular smooth muscle.
65. Simard E, Kovacs JJ, Miller WE, Kim J, Grandbois M, et al. (2013) B-arrestin regulation of myosin light chain phosphorylation promotes AT1aR-mediated cell contraction and migration. PloS one In Press.
66. Solon J, Levental I, Sengupta K, Georges PC, Janmey PA. (2007) Fibroblast adaptation and stiffness matching to soft elastic substrates. Biophys J 93: 4453-4461. PMID: 18045965
67. Chuah YK, Basir R, Talib H, Tie TH, Nordin N. (2013) Receptor for advanced glycation end products and its involvement in inflammatory diseases. Int J Inflam 2013: 403460. doi: 10.1155/2013/403460 PMID: 24102034
68. Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, et al. (1999) Diabetes and cardiovascular disease: A statement for healthcare professionals from the american heart association. Circulation 100: 1134-1146. PMID: 10477542
69. Dyer DG, Dunn JA, Thorpe SR, Bailie KE, Lyons TJ, et al. (1993) Accumulation of maillard reaction products in skin collagen in diabetes and aging. J Clin Invest 91: 2463-2469. PMID: 8514858
70. McCance DR, Dyer DG, Dunn JA, Bailie KE, Thorpe SR, et al. (1993) Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. J Clin Invest 91: 2470-2478. PMID: 8514859
71. Yamamoto Y, Yamamoto H. (2013) RAGE-mediated inflammation, type 2 diabetes, and diabetic vascular complication. Front Endocrinol (Lausanne) 4: 105.
72. Yan SF, Ramasamy R, Schmidt AM. (2010) The RAGE axis: A fundamental mechanism signaling danger to the vulnerable vasculature. Circ Res 106: 842-853. doi: 10.1161/CIRCRESAHA.109.212217 PMID: 20299674
73. Yan SF, Ramasamy R, Naka Y, Schmidt AM. (2003) Glycation, inflammation, and RAGE: A scaffold for the macrovascular complications of diabetes and beyond. Circ Res 93: 1159-1169. PMID: 14670831